Enveric Biosciences Inc (ENVB)
0.98
+0.05
(+5.89%)
USD |
NASDAQ |
May 03, 10:58
Enveric Biosciences Cash from Investing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.0169M |
| March 31, 2023 | -0.0052M |
| December 31, 2022 | -0.0062M |
| September 30, 2022 | -0.0186M |
| June 30, 2022 | -0.0539M |
| March 31, 2022 | -0.5055M |
| December 31, 2021 | -0.1897M |
| September 30, 2021 | 3.055M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.675M |
| December 31, 2020 | -0.0441M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.0434M |
| March 31, 2020 | -0.0434M |
| December 31, 2019 | -0.0566M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.1158M |
| March 31, 2019 | -0.1119M |
| December 31, 2018 | 0.018M |
| September 30, 2018 | -2.574M |
| June 30, 2018 | -0.0139M |
| March 31, 2018 | -1.069M |
| December 31, 2017 | -0.1064M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.0027M |
| March 31, 2017 | -0.0662M |
| December 31, 2016 | -1.158M |
| September 30, 2016 | -2.155M |
| June 30, 2016 | -1.512M |
| March 31, 2016 | -1.767M |
| September 30, 2015 | 3.688M |
| June 30, 2015 | -1.090M |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.675M
Minimum
Mar 2021
3.055M
Maximum
Sep 2021
0.0738M
Average
-0.0062M
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| Seelos Therapeutics Inc | -- |
| Societal CDMO Inc (DELISTED) | -0.734M |
| Cardiff Oncology Inc | 13.56M |
| BioVie Inc | 0.00 |
| Adial Pharmaceuticals Inc | 0.35M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.751M |
| Cash from Financing (Quarterly) | -0.1861M |
| Free Cash Flow | -14.10M |
| Free Cash Flow Per Share (Quarterly) | -0.7664 |
| Free Cash Flow Yield | -666.4% |